Početna › Srpasto stanica › Florida
Kliničke studije za Srpasto stanica u državi Florida
9 studija za Srpasto stanica traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- University of Florida, Jacksonville
U tijeku regrutacijaFaza 3
Od 12 do 100 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT06439082A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Memorial Healthcare, Hollywood
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT06612268A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Edward Jenner Research Group LLC., Plantation
- Pediatric Hematology / Oncology a division of Kidz Medical services, West Palm Beach
- St. Mary's Medical Center, West Palm Beach
U tijeku regrutacijaFaza 2/3
Od 12 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- University of Florida Hemophilia Treatment Center, Gainesville
- University of Miami Comprehensive Hemophilia Treatment Center, Miami
- University of Miami Hospital and Clinics, Miami
- i još 4
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 17. kol 2026. · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Golisano Children's Hospital, Fort Myers
- The Foundation for Sickle Cell Disease, Hollywood
U tijeku regrutacijaFaza 2
Od 12 godina i više · Oba spola · Ažurirano 14. kol 2026. · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- The Foundation for Sickle Cell Disease, Hollywood
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Oncology & Hematology Associates of West Broward- Site Number : 8400029, Coral Springs
- Sylvester Comprehensive Cancer Center- Site Number : 8400020, Miami
U tijeku regrutacijaFaza 3
Od 10 do 65 godina · Oba spola · Ažurirano 29. srp 2026. · NCT06975865Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- University of Florida, Gainesville
U tijeku regrutacijaFaza 2
6 Months – 21 Years · Oba spola · Ažurirano 27. srp 2026. · NCT02675959A Long-term Follow-up Study in Patients Who Received BEAM-101
- Mayo Clinic Florida, Jacksonville
U tijeku regrutacijaOpažajna studija
Od 14 do 37 godina · Oba spola · Ažurirano 28. sij 2026. · NCT07373639Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.